NEWSLETTER
ISSUE
Issue Jan to Mar, 2026 Volume 24
Alliance Updates: Zermec Pharma AG Partnership
Pharmalab India Private Limited is pleased to announce our strategic partnership with Zermec Pharma AG, a leading Swiss provider of high-quality containment solutions for powder handling applications. Zermec Pharma AG is headquartered at Laufenburg, Switzerland.
This collaboration introduces Zermec’s advanced containment valve technology to the Indian pharmaceutical market, reinforcing our commitment to deliver cutting-edge safety solutions for handling potent active pharmaceutical ingredients and hazardous materials. Like our previous alliance announcements, this partnership enhances our portfolio with proven European engineering tailored for global standards.
Introducing Zermec Pharma AG
Zermec Pharma AG stands as your innovative and solution-oriented partner, specializing in comprehensive containment systems for the pharmaceutical, biotechnology, and chemical industries. With nearly all development and production processes managed in-house at their Swiss facility, Zermec ensures exceptional quality and reliability in every product. Their expertise focuses on enabling safe, dust-free material transfers, helping manufacturers meet stringent regulatory requirements while optimizing operational efficiency, supported by services like on-site engineering, training, Factory Acceptance Testing, and qualification protocols.
Importance of Containment Systems
Containment systems play a vital role in the pharmaceutical industry by safeguarding operators from exposure to hazardous substances, preventing cross-contamination between batches, and maintaining product integrity during high-risk processes like powder handling and filling. Zermec’s ZCV achieves Occupational Exposure Band Level better than 5(below 0.1 µg/m³) without using any dust extraction. Thus, for highly potent compounds in India’s booming pharmaceutical sector serving global markets. In the Indian market, where pharmaceutical production is expanding rapidly to serve both domestic and export demands, these systems address growing needs for advanced safety measures amid stricter global compliance standards from agencies like the United States Food and Drug Administration and the European Medicines Agency. By integrating such technologies, companies can achieve high containment levels—ensuring airborne particle concentrations remain below safe thresholds—while supporting scalable manufacturing for highly potent compounds.
Spotlight on Zermec Containment Valve System
At the heart of this partnership is Zermec’s ZCV containment valve—a smart split butterfly design that safely handles highly potent powders and granules without dust extraction systems. Its active and passive parts connect securely between process equipment and intermediate bulk containers in sizes from 50 to 250 millimetres, available as easy-to-use manual versions or automated pneumatic ones that withstand pressures up to 6 bar.
Made with durable stainless steel or Hastelloy parts and robust seals, the lightweight passive side simplifies cleaning and sterilization across a wide temperature range. Standout features include double seals to keep powder out, smooth surfaces for quick wiping, tool-free disk swaps using clever frames, and add-ons like wash hoods and flexible connectors that minimize downtime—all fully compatible with standard cleaning and sterilization methods.
Built on over 25 years of proven performance from its Müller origins and aligned with Good Manufacturing Practices, the ZCV brings top precision, safety, and efficiency to filling, sampling, and material transfer tasks worldwide. This technology empowers pharmaceutical facilities to handle powders and granules with unmatched precision, reducing risks and enhancing productivity across filling, sampling, and transfer applications.
